Search Results

Focus on... Linezolid: a synthetic oxazolidinone antimicrobial for treatment of serious gram-positive infections.

• Authors : Cupo-Abbott J (AUTHOR); Louie SG (AUTHOR); Rho JP (AUTHOR)

• Source: Formulary. Jun2000, Vol. 35 Issue 6, p483-490. 5p.

Record details

Linezolid.

• Authors : Cupo-Abbott, Jennifer; Louie, Stan G.; Rho, Jay P.

Subjects: ANTI-infective agents; GRAM-positive bacterial infections

• Source: Formulary. Jun2000, Vol. 35 Issue 6, p483. 7p. 1 Diagram, 3 Charts.

Record details

New antibiotic class effectively treats challenging gram-positive infections.

Subjects: ANTIBIOTICS; GRAM-positive bacterial infections; DRUG efficacy

• Source: Formulary. Nov99, Vol. 34 Issue 11, p967. 1/2p.

Record details

Psychiatric Adverse Effects of Antibiotics.

• Authors : Skelly, Megan K.; Wattengel, Bethany A.; Starr, Kaitlyn E.

Subjects: MENTAL illness risk factors; ANTIBIOTICS; BETA lactam antibiotics

• Source: Psychiatric Times; Nov2019, Vol. 36 Issue 11, p14-16, 3p

Record details

Antimicrobial Resistance: Stewardship and Strategies for Conquering a Global Threat.

• Authors : Pyrek, Kelly M.

• Source: Infection Control Today; Oct2018, Vol. 22 Issue 10, p12-24, 6p

Record details

Antibiotic formulary guidelines for health systems: Balancing evidence and stewardship.

• Authors : Harper, Gina Lumbard

Subjects: ANTIBIOTICS; DRUG resistance in microorganisms; HEALTH facilities

• Source: Formulary. Oct2013, Vol. 48 Issue 10, p332-338. 5p.

Record details

Telithromycin: a once-daily, broad-spectrum ketolide for treatment of various respiratory infections.

• Authors : Preston SL (AUTHOR); Drusano GL (AUTHOR)

• Source: Formulary. Feb2001, Vol. 36 Issue 2, p101-110. 7p.

Record details

NME, Biologic Approvals.

Subjects: DRUGS; BIOLOGICALS; UNITED States. Food & Drug AdministrationUNITED States

• Source: Formulary. Feb2001, Vol. 36 Issue 2, p164. 4p. 1 Chart, 1 Graph.

Record details

Telithromycin.

• Authors : Preston, Sandra L.; Drusano, George L.

Subjects: ANTI-infective agents; RESPIRATORY infection treatment; PHARMACOLOGYUNITED States

• Source: Formulary. Feb2001, Vol. 36 Issue 2, p101. 7p. 1 Diagram, 4 Charts.

Record details

Pharmacia Corporation.

Subjects: PHARMACIA Corp.; PHARMACEUTICAL industry

• Source: Formulary. Oct2000 Resource Guide, Vol. 35 Issue 10, p77. 6p. 2 Charts.

Record details